Selvas AI, an artificial intelligence company, announced on the 12th that it is expanding its AI medical platform business based on its central monitoring solution (CMS).
CMS (Central Monitoring Solution) is a core software platform for integrated management and monitoring of data generated from wired and wireless medical devices within hospitals. The system is being built on the medical device infrastructure of its affiliate, Mediana. According to the company, the relevant medical device approval process is currently underway and is expected to be completed within the second quarter of this year.
CMS is a central control system that integrates and analyzes patient biometric data collected from various medical devices and wearable devices used in hospitals in real time and provides it to medical staff. This supports patient condition monitoring and data-driven medical decisions.
While the existing CMS was structured around approximately 32 patient monitoring devices (PMDs), the CMS currently undergoing approval is characterized by its expansion to enable integrated management of patient data across the entire hospital, beyond the ward level.
It is also designed to improve hospital operational efficiency by integrating and managing data generated from various wearable medical devices, such as wearable electrocardiogram (ECG) equipment, and AI medical services, and providing functions such as real-time notifications, patient status analysis, and medical staff decision-making support.
Mediana's patient monitoring devices are key pieces of equipment used in hospitals to measure patients' vital signs in real time, serving as data collection devices for AI-based healthcare services. Selvas AI is pursuing an AI healthcare platform business by combining its proprietary AI and software technologies with the medical device foundation acquired through the acquisition of Mediana.
The company is also developing various AI medical solutions, starting with CMS, and plans to gradually release related services within this year.
This AI medical platform strategy is also driving improved performance. Selvas AI reported improved profitability last year, with operating profit increasing 60.2% year-on-year. The company explained that the established business structure, which combines medical device hardware, AI, and software technologies, is resulting in group-wide synergies and increased sales.
Going forward, Selvas AI plans to expand the scope of its platform by developing various AI medical services to improve hospital work efficiency, such as AI-based diagnosis prediction and clinical support services.
Kwak Min-cheol, CEO of Selvas AI, said, “Through joint research and development between Selvas AI and Mediana, the medical platform business combining AI, software, and medical device hardware technologies is gaining momentum.” He added, “Based on medical device infrastructure and AI technology, we will build an AI medical platform that connects the entire hospital and expand business opportunities in the global medical market.”
Meanwhile, as the digital healthcare market, which combines medical data and artificial intelligence technology, expands, industry interest in integrated monitoring platforms and AI medical solutions that enhance hospital operational efficiency is also growing.
- See more related articles
You must be logged in to post a comment.